共 50 条
- [2] Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes [J]. DIABETES OBESITY & METABOLISM, 2015, 17 (09): : 859 - 867
- [4] Comparative clinical efficacy and safety of insulin glargine 300 U/ml (Toujeo) versus insulin glargine 100 U/ml in type 2 diabetes and type 1 diabetes: A systematic literature review and meta-analysis [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (06): : 1589 - 1606
- [9] Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetes [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (03): : 541 - 548